The UACR continues active collaboration with the GCPpl (Polish Association for Good Clinical Practice). The polish partners shared their training materials used for the advanced training of the professionals. The UACR translated these materials in Ukrainian and you can find it on the site of the UACR:

We are happy to inform you that UACR made the translation of the licensed materials, produced by Center for Information and Study on Clinical Research Participation (CISCRP). CISCRP is non-profit organization and its activity is dedicated to the educating and informing the public, patients, caregivers, medical/research communities, the media and policy makers about clinical research and the role each party plays in the process. The UACR continues cooperation with the CISCRP in translation of the brochures for the patients so that everyone had the opportunity to get comprehensive information about the importance of the clinical research, the rights and obligations of the all participants, develop a positive attitude to the trials in the community. You can find the translated materials on the site of the UACR in the section For patients for free without registration. The UACR is the official partner of the CISCRP.

The collaboration of the Ukrainian Association for Clinical Research and CISCRP (Center for Information and Study on Clinical Research Participation ) is being continued. The UACR got the original educational brochures for patients and other participants of the clinical trials with the right for translating it into Ukrainian and further posting on the CISCRP site.

On the site of the Ukrainian Association for clinical research we have made new function 'Donate' for the development of the UACR. It includes creation of patient portal, design of the UACR site, organizing of master-classes and trainings.
Please, join!

The World Health Organization declared the pandemic state of coronavirus infection COVID-2019 . Worldwide restrictive measures, including Ukraine, can cause the process of clinical trials significantly and concern the interests of all investigated subjects. The regulatory organs of different countries have already responded to these changes. For example, FDA has published the Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. MHRA has explained its opinion regarding a predicted increase of protocol deviations. The State expert center of the Ukrainian Ministry of Health published its "Recommendations about conduction of clinical trials in the conditions of coronavirus infection spreading". The pandemic is going to be a catalyst for the development of “site-less” clinical trials (virtual, decentralized, digital, hybrid, etc.) in our area. We propose you to get acquainted with the future of virtual clinical trials with materials prepared by the partners of the Ukrainian Association for Clinical Research.

  • 1
  • 2
Page 1 of 2